류주희 (한국과학기술연구원)님 | 한빛사연구자 > 한빛사

Characterization of Non-Specific Electrostatic Interactions of Cationic Peptides with DNA Origami and Their Functional Consequences

Targeting and exploiting macropinocytosis in cancer therapy

J. Control. Release, Jun 16 2025, S0168-3659(25)00582-6 | https://doi.org/10.1016/j.jconrel.2025.113962

Receptor-ligand interactions for optimized endocytosis in targeted therapies

J. Control. Release, Jan 26 2025, S0168-3659(25)00070-7 | https://doi.org/10.1016/j.jconrel.2025.01.060

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade

Adv. Drug Deliv. Rev., Available online 16 April 2024, 115306 | https://doi.org/10.1016/j.addr.2024.115306

Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination

Predicting response to anti-EGFR antibody, cetuximab, therapy by monitoring receptor internalization and degradation

Biomaterials, Volume 303, December 2023, 122382 | https://doi.org/10.1016/j.biomaterials.2023.122382

Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment

Controlled spatial characteristics of ligands on nanoparticles: Determinant of cellular functions

J. Control. Release, Vol 360, Aug 2023, Pages 672-686 | https://doi.org/10.1016/j.jconrel.2023.07.020

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Biomaterials, Available online 1 April 2021, 120791 | https://doi.org/10.1016/j.biomaterials.2021.120791

Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity

Adv. Mater., First published: 09 October 2020 | https://doi.org/10.1002/adma.202002197

저자논문